Abstracts

Search by keyword or author name.

Showing 852 abstracts.

M Boivin, M Chernoff, B Laughton, B Zimmer, C Joyce, L Barlow-Mosha, M Bwakura-Dangarembizi, M Ratswana, L Fairlie, P Kamthunzi, K McCarthy, P Jean-Philippe, A Violari, M Cotton, P Palumbo. African multi-site 2-year study of neurocognition in HIV infected/affected children. Presented at: CROI 2018; 2018 Mar 06.

Conference

CROI 2018

Study

P1104s
Priyanka Uprety, Kaitlin Rainwater-Lovett, Ellen Chadwick, Edmund Capparelli, Carrie Ziemniak, Katherine Luzuriaga, Larry Moulton, Deborah Persaud. Age of Antiretroviral Treatment on Decay and HIV-1 DNA Reservoir Size during Infancy. Presented at: CROI 2015.

Conference

CROI 2015

Study

P1030
Deborah S. Storm, R.N.,Ph.D, Joan H. Skurnick, Yan He, M.S., Mary D. Boland, R.N., M.S.N, D.P.H., Lois C. Howland, M.S., M.P.H., D.Ph., James M. Oleske, M.D. Age, Symptom Assessment and Reporting in Children and Youth with HIV Infection During 1993-2000. Presented at: Eastern Nursing Research Society 2004.

Conference

Eastern Nursing Research Society 2004
Age-Related Differences in Plasma and Intracellular (IC) Tenofovir (TFV) Concentrations.
Edmund Capparelli, Pharm.D., Brian Robbins, Ph.D., Mobeen H. Rathore, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Adriana Weinberg, M.D., Renee Browning, R.N., M.S.N, Rohan Hazra, M.D., Ross E. McKinney, Jr., M.D., Michael Rochon-Duck. Age-Related Pharmacokinetics of Efavirenz Solution. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Conference

16th Conference on Retroviruses & Opportunistic Infections

Study

P1021
James M. Oleske, M.D., Mary Glenn Fowler, M.D., M.P.H., Michael T. Brady, M.D. AIDS Clinical Trials Group (ACTG) Protocol 219: A PediatricHIV Late Outcomes Protocol.
Kumud K. Singh, Akihiko Saitoh, M.D., Christine Powell, M.A., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Stuart E. Starr, M.D., Stephen A. Spector, M.D. Allelic Variants of MDRI Alter Pharmacokinetics of Nelfinavir Resulting in Higher Drug Levels and More Rapid Decline in Plasma HIV-1 RNA in Children.
Grace M. Ahimbisibwe, Yanling Huo, Lisa Aaron, Joseph Szewczyk, Adit Dhummakupt, Damayanti Yengkhom, Aaron A.R. Tobian, Avy Violari, Mark Cotton, Amita Gupta, Adriana Weinberg, Philippa Musoke, Deborah Persaud. An analysis of changes in HIV-1 Proviral DNA in Women with HIV from antepartum through 48 weeks postpartum in the IMPAACT P1078 study. Presented at: International AIDS Conference; 2026 Jul 26; Rio de Janeiro, Brazil.

Conference

International AIDS Conference

Study

P1078

Conference Location

Rio de Janeiro, Brazil
Wayne M. Dankner, M.D., Sharon Appelbaum Nachman, M.D., Michael Hughes, Ph.D., Philimon Gona, Ph.D., Sharon Huang, M.S., Sharon Huang, M.S., Carol Elgie, B.S., Ram Yogev, M.D. An Observational Study of the Rate of Opportunistic Infection (OI) Events In HIV-Infected Children Who Have Demonstrated Immunologic Reconstitution And Who Have Discontinued OI Prophylaxis.

Study

P1008
Ann J. Melvin, M.D., M.P.H. An Observational Study of Vertical Transmission When the Mother But Not the Infant Received Oral Zidovudine.